09926.HK
Akeso, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 101.20
+11.45%Margins
Gross margin
77.9%
EBITDA margin
-25.8%
EBIT margin
-24.7%
Net margin
-30.4%
FCF margin
-17.1%
-21.2%
Return on equity
-11.1%
Return on assets
-10.8%
Return on invested capital
0.37x
Asset turnover
-HKD 1.1B
Cash from operations
HKD 12
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026